Citations - Publications
CITING and acknowledging SFR Biosciences IN YOUR PUBLICATIONS
SFR Biosciences citation within publications
One of the most important ways of assessing our impact is through the record of scientific outputs produced by the research teams using our facilities. To showcase our contribution to your projects, it is paramount that you mention the support from the SFR Biosciences in your publications. You need to state the core facilities used and name the staff who has provided help. Depending on their role, staff should either be mentioned in the acknowledgement section or listed as co-authors.
Please also inform the facility managers of your publications when they are accepted.
suggested sentance to include in your manuscri)pt:
“We acknowledge the contribution of SFR Biosciences (Universite Claude Bernard Lyon 1, CNRS UAR3444, Inserm US8, ENS de Lyon) [Core Facility Name] or “the help of the staff of - [Core Facility Name], especially - [Name Surname], for assistance with [technique]”.
FOR AFFILIATION, THE ADRESSE TO BE INDICATED IS:
“Universite Claude Bernard Lyon 1, CNRS UAR3444, Inserm US8, ENS de Lyon, SFR Biosciences, Lyon 69007, France”. (University Lyon 1 Signature Charter, July 2023)
PUBLICATIONS OF WORK CARRIED OUT USING HELIOS (CYTOF2) OR Imagestream X:
Must clearly acknowledge the Equipex PHENOCAN by mentioning the ANR reference of the Equipex: contracts ANR -11-EQPX-0035 PHENOCAN.
PUBLICATIONS OF WORK CARRIED OUT USING ANIRA PLATFORMS (pbes, CYTOMETRY, L3, VECTOROLOGY, GENETIC ANALYSIS):
It should contain: “We acknowledge the contributions of the CELPHEDIA Infrastructure (http://www.celphedia.eu/), especially the center AniRA in Lyon”.
AKNOWLEDGEMENTS TO Équipex spatial-cell-id:
"This work was supported by the ÉquipEx+ Spatial-Cell-ID under the "Investissements d'avenir" program (ANR-21-ESRE-00016)".
publications OF WORK CARRIED OUT USING PLATIM PLATFORM
"We acknowledge the LyMIC-PLATIM, member of the national infrastructure France-BioImaging supported by the French National Research Agency (ANR-24-INBS-0005 FBI BIOGEN)".
